Interpretation of 2020 expert consensus statement on neuroprotection after cardiac arrest in China (Ⅲ): drug therapy

李震中,冯立群,马青变,王涛,李永秋,赵斌,覃秀川,李清熙,吴世政,孙红斌,袁军,楚兰,武剑,顾宇翔,彭继茂,陈志,樊东升
DOI: https://doi.org/10.11817/j.issn.1673-9248.2021.06.001
2021-01-01
Abstract:Neuroprotection is one of the key measures for successful cardiopulmonary resuscitation with good prognosis for patients with cardiac arrest (CA). Although the success rate of cardiopulmonary resuscitation has increased, the prognosis of patients with CA after cardiopulmonary resuscitation has not been significantly improved due to insufficient follow-up treatment of cardiopulmonary resuscitation. In order to reduce brain damage and improve the survival and neurological prognosis of patients with CA, we interpreted the part of drug treatment in 2020 experts consensus statement on neuroprotection after CA in China, which mainly involved the treatments of brain protection and drug therapy selection .
What problem does this paper attempt to address?